Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

The Impact of Comorbidity on Quality of Life in Chronic Myeloid Leukemia Patients with Deep Molecular Response Who Stopped Therapy By Tyrosine Kinase Inhibitors: Results of the RU-SKI Trial

Tatyana Ionova, PhD Professor, Tatiana Nikitina, PhD, Natalia Porfirieva, Anna Petrova, MD, Ekaterina Yu. Chelysheva, MD PhD, Oleg A. Shukhov, MD PhD, Anastasiya Bykova, MD, Galina Gusarova, MD PhD, Irina Nemchenko, MD PhD, Nikolay Tsyba, MD PhD, Anna G. Turkina, Prof., MD

Blood (2019) 134 (Supplement_1): 2925.

https://doi.org/10.1182/blood-2019-122041

Published: 2019

Journal Articles

Benefits of Aquatic Therapy in Pediatric Patients with Sickle Cell Disease

Sarah Leonard, MDMPH, Lindsay Cortright, MA, Dmitry Tumin, PhD, Lora Joyner, MS, PT, PCS, Sruthipriya Sridhar, MD

Blood (2019) 134 (Supplement_1): 4846.

https://doi.org/10.1182/blood-2019-129163

Published: 2019

Journal Articles

Estimating the Burden of Intracranial Hemorrhage in Persons with Hemophilia A using Administrative Claims Data

Arash Mahajerin, MD MS, Anisha M. Patel, PhD, Erru Yang, MS, Chinelo C. Orji, MS, Richard H. Ko, MD

Blood (2019) 134 (Supplement_1): 2398.

https://doi.org/10.1182/blood-2019-123713

Published: 2019

Journal Articles

Dasatinib Discontinuation in Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DASFREE)

Neil P. Shah, MD PhD, Jose Valentín García Gutiérrez, PhD, Antonio Jiménez-Velasco, MD, Sarah M Larson, MD, Susanne Saussele, MD, Delphine Rea, MD, François-Xavier Mahon, MD PhD, Moshe Levy, MD, María Teresa Gómez-Casares, MD PhD, Fabrizio Pane, MD, Franck-Emmanuel Nicolini, MD PhD, Michael J. Mauro, MD, Oumar Sy, PhD, Patricia Martin-Regueira, MD, Jeffrey H. Lipton, PhD MD FRCPC

Blood (2017) 130 (Supplement 1): 314.

https://doi.org/10.1182/blood.V130.Suppl_1.314.314

Published: 2017

Journal Articles

Frontline Therapy with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Induction Followed By Autologous Stem Cell Transplantation, Krd Consolidation and Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma (NDMM) Patients: Primary Results of the Intergroupe Francophone Du MyéLome (IFM) Krd Phase II Study

Murielle Roussel, MD, Valerie Lauwers-Cances, MD, Nelly Robillard, PhD, Karim Belhadj, MD, Thierry Facon, MD PhD, Laurent Garderet, MD, Martine Escoffre, MD, Brigitte Pegourie, MD, Lotfi Benboubker, MD PhD, Denis Caillot, Cecile Fohrer, MD, Philippe Moreau, Xavier Leleu, Herve Avet-Loiseau, MD PhD, Michel Attal

Blood (2016) 128 (22): 1142.

https://doi.org/10.1182/blood.V128.22.1142.1142

Published: 2016

Journal Articles

Natural History of Non-Infectious, Ibrutinib-Attributable Adverse Events Leading to Alternative BTK Inhibitor Use in CLL

Polina Shindiapina, MD PhD, Soun Khountham, Kerry A. Rogers, MD, Jeffrey Jones, MD MPH, Leslie Andritsos, MD, Kami J. Maddocks, MD, Joseph M. Flynn, DO, MPH, Jennifer A. Woyach, MD, John C. Byrd, MD, Farrukh T. Awan

Blood (2016) 128 (22): 4385.

https://doi.org/10.1182/blood.V128.22.4385.4385

Published: 2016

Journal Articles

Ibrutinib in Early Stage CLL: Preliminary Safety Results of a Placebo-Controlled Phase III Study

Petra Langerbeins, MD, Jasmin Bahlo, Christina Rhein, Paula Cramer, MD, Anna-Maria Fink, MD, Natali Pflug, MD, Julia von Tresckow, MD, Stephan Stilgenbauer, MD, Karl-Anton Kreuzer, Michael J. Eckart, MD, Ursula Vehling-Kaiser, MD, Rudolf Schlag, MD, Christina Balser, MD, Lothar Müller, MD, Clemens-Martin Wendtner, MD, Kirsten Fischer, MD, Barbara Eichhorst, MD, Michael Hallek, MD

Blood (2015) 126 (23): 2934.

https://doi.org/10.1182/blood.V126.23.2934.2934

Published: 2015

Journal Articles

An Ongoing Multinational Observational Study in Multiple Myeloma (PREAMBLE): Preliminary Report on Patient Survival

Gordon Cook, MD PhD, David Cella, PhD, Brian Durie, MD, Hartmut Goldschmidt, MD, David Kuter, MD DPhil, Philippe Moreau, Ravi Vij, MD MBBS, Catherine Davis, Abderrahim Oukessou, Teresa Zyczynski, PharmD, MPH, MBA, BSPharm, Sergey Popov, Antonio Palumbo, MD

Blood (2015) 126 (23): 2093.

https://doi.org/10.1182/blood.V126.23.2093.2093

Published: 2015

Journal Articles

Impact Of Low-Grade Adverse Events (AEs) On Health-Related Quality Of Life (HRQoL) In Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia In Chronic Phase (Ph+ CML-CP) From The Enestnd Trial: 48-Month Follow-Up

Lei Chen, MD, PhD, Annie Guerin, MSc, Maryna Marynchenko, MBA, Raluca Ionescu-Ittu, PhD, Robert Hiscock, MSc, Roy Nitulescu, MA, Chopra Pooja, MSc, Ling-I Hsu, MPH, Christopher Keir, MD, Eric Qiong Wu, PhD

Blood (2013) 122 (21): 4038.

https://doi.org/10.1182/blood.V122.21.4038.4038

Published: 2013

Journal Articles

Burden of Morbidity in 10+ Year Survivors of Hematopoietic Cell Transplantation (HCT): A Report From the Bone Marrow Transplant Survivor Study (BMTSS)

Can-Lan Sun, Ph.D, John H. Kersey, MD, Liton Francisco, B.S., K. Scott Baker, MD, MS, Saro H. Armenian, DO, MPH, Daniel J. Weisdorf, MD, Forman Stephen, M.D., Smita Bhatia, MD, MPH

Blood (2011) 118 (21): 841.

https://doi.org/10.1182/blood.V118.21.841.841

Published: 2011

Journal Articles

Neoangiogenesis contributes to the development of hemophilic synovitis

Suchitra S. Acharya, Rosandra N. Kaplan, Dan Macdonald, Oluwa T. Fabiyi, Donna DiMichele, David Lyden

Blood (2011) 117 (8): 2484–2493.

https://doi.org/10.1182/blood-2010-05-284653

Published: 2011

Journal Articles

Late Hospitalizations in Long-Term Survivors of Hematopoietic Cell Transplantation (HCT): Report From the Bone Marrow Transplant Study (BMTSS).

Melanie D Sabado, Can-Lan Sun, Liton Francisco, K. Scott Baker, Daniel Weisdorf, MD, Stephen J. Forman, MD, Smita Bhatia

Blood (2009) 114 (22): 807.

https://doi.org/10.1182/blood.V114.22.807.807

Published: 2009

Journal Articles

Long Term Outcomes of Unrelated Donor Bone Marrow Transplantation in Children with Severe Aplastic Anemia: An Update of the Milwaukee Experience.

Julie-An Talano, MD, Bruce Camitta, MD, Carolyn Keever-Taylor, Ph.D., Lynnette Anderson, PNP, Caitlin Wallach, James Casper, MD, David Margolis, MD

Blood (2006) 108 (11): 3128.

https://doi.org/10.1182/blood.V108.11.3128.3128

Published: 2006

Journal Articles

Predictors of the Development of Post-Thrombotic Syndrome after Acute Symptomatic Deep Vein Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study).

Susan R. Kahn, MD, Thierry Ducruet, Louise Arsenault, Marie Jose Miron, MD, Andre Roussin, MD, Sylvie Desmarais, MD, France Joyal, MD, Jeannine Kassis, MD, Susan Solymoss, MD, Jeffrey S. Ginsberg, MD, Louis Desjardins, MD, Mira Johri, PhD, Donna L. Lamping, PhD, Ian Shrier, MD, PhD

Blood (2005) 106 (11): 1635.

https://doi.org/10.1182/blood.V106.11.1635.1635

Published: 2005

Journal Articles

Delayed Treatment of Bleeding in Patients with Mild Hemophilia Can Very Significantly Affect Overall Need for Therapy.

D. Goodyear, M.F. Scully, M. Kawaja

Blood (2005) 106 (11): 4049.

https://doi.org/10.1182/blood.V106.11.4049.4049

Published: 2005

NARROW

The Impact of Comorbidity on Quality of Life in Chronic Myeloid Leukemia Patients with Deep Molecular Response Who Stopped Therapy By Tyrosine Kinase Inhibitors: Results of the RU-SKI Trial

Benefits of Aquatic Therapy in Pediatric Patients with Sickle Cell Disease

Estimating the Burden of Intracranial Hemorrhage in Persons with Hemophilia A using Administrative Claims Data

Dasatinib Discontinuation in Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DASFREE)

Natural History of Non-Infectious, Ibrutinib-Attributable Adverse Events Leading to Alternative BTK Inhibitor Use in CLL

Ibrutinib in Early Stage CLL: Preliminary Safety Results of a Placebo-Controlled Phase III Study

An Ongoing Multinational Observational Study in Multiple Myeloma (PREAMBLE): Preliminary Report on Patient Survival

Impact Of Low-Grade Adverse Events (AEs) On Health-Related Quality Of Life (HRQoL) In Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia In Chronic Phase (Ph+ CML-CP) From The Enestnd Trial: 48-Month Follow-Up

Burden of Morbidity in 10+ Year Survivors of Hematopoietic Cell Transplantation (HCT): A Report From the Bone Marrow Transplant Survivor Study (BMTSS)

Neoangiogenesis contributes to the development of hemophilic synovitis

Late Hospitalizations in Long-Term Survivors of Hematopoietic Cell Transplantation (HCT): Report From the Bone Marrow Transplant Study (BMTSS).

Long Term Outcomes of Unrelated Donor Bone Marrow Transplantation in Children with Severe Aplastic Anemia: An Update of the Milwaukee Experience.

Predictors of the Development of Post-Thrombotic Syndrome after Acute Symptomatic Deep Vein Thrombosis: Two-Year Results from a Canadian Multicenter Prospective Cohort Study (The VETO Study).

Delayed Treatment of Bleeding in Patients with Mild Hemophilia Can Very Significantly Affect Overall Need for Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only